Fifth Third Bancorp Emergent Bio Solutions Inc. Transaction History

Fifth Third Bancorp

$27.1 Billion
Q4 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	SELL	$3.17 - $7.91 $380 - $949	-120 Reduced 24.34%	373 $1,000
Q2 2023 Jul 25, 2023	SELL	$7.35 - $13.21 $411 - $739	-56 Reduced 10.2%	493 $3,000
Q1 2023 Apr 24, 2023	BUY	$7.79 - $16.29 $1,355 - $2,834	174 Added 46.4%	549 $5,000
Q4 2022 Jan 25, 2023	BUY	$11.0 - $21.45 $3,102 - $6,048	282 Added 303.23%	375 $0
Q3 2022 Oct 25, 2022	SELL	$20.09 - $35.8 $1,366 - $2,434	-68 Reduced 42.24%	93 $2,000
Q2 2022 Aug 04, 2022	SELL	$27.42 - $43.63 $1,453 - $2,312	-53 Reduced 24.77%	161 $5,000
Q1 2022 Apr 19, 2022	BUY	$36.48 - $52.22 $583 - $835	16 Added 8.08%	214 $9,000
Q4 2021 Feb 01, 2022	SELL	$33.11 - $55.01 $175,747 - $291,993	-5,308 Reduced 96.4%	198 $9,000
Q3 2021 Oct 15, 2021	BUY	$50.07 - $66.05 $450 - $594	9 Added 0.16%	5,506 $276,000
Q2 2021 Aug 06, 2021	SELL	$56.61 - $80.46 $175,151 - $248,943	-3,094 Reduced 36.01%	5,497 $346,000
Q1 2021 May 07, 2021	BUY	$86.23 - $125.19 $16,901 - $24,537	196 Added 2.33%	8,591 $798,000
Q4 2020 Feb 16, 2021	SELL	$79.17 - $111.47 $72,598 - $102,217	-917 Reduced 9.85%	8,395 $752,000
Q3 2020 Nov 09, 2020	BUY	$81.91 - $134.94 $350,902 - $578,082	4,284 Added 85.2%	9,312 $962,000
Q2 2020 Aug 05, 2020	BUY	$54.33 - $89.52 $20,428 - $33,659	376 Added 8.08%	5,028 $398,000
Q1 2020 May 05, 2020	SELL	$49.34 - $68.76 $89,897 - $125,280	-1,822 Reduced 28.14%	4,652 $269,000
Q4 2019 Feb 14, 2020	SELL	$51.21 - $59.06 $70,874 - $81,739	-1,384 Reduced 17.61%	6,474 $349,000
Q3 2019 Nov 14, 2019	SELL	$40.6 - $57.2 $14,413 - $20,306	-355 Reduced 4.32%	7,858 $411,000
Q2 2019 Aug 07, 2019	BUY	$39.92 - $53.86 $9,061 - $12,226	227 Added 2.84%	8,213 $397,000
Q1 2019 May 14, 2019	SELL	$48.23 - $66.16 $12,973 - $17,797	-269 Reduced 3.26%	7,986 $403,000
Q4 2018 Feb 14, 2019	SELL	$55.63 - $73.24 $96,239 - $126,705	-1,730 Reduced 17.33%	8,255 $489,000
Q3 2018 Nov 14, 2018	SELL	$52.05 - $66.51 $112,584 - $143,861	-2,163 Reduced 17.81%	9,985 $657,000
Q2 2018 Aug 14, 2018	SELL	$48.33 - $55.64 $6,234 - $7,177	-129 Reduced 1.05%	12,148 $613,000
Q1 2018 May 15, 2018	BUY	$44.44 - $54.39 $545,589 - $667,746	12,277 New	12,277 $646,000

Others Institutions Holding EBS

# of Institutions

172

Shares Held

36.8M

Call Options Held

336K

Put Options Held

203K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $384M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account